Stay updated on Pembrolizumab Combo in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in mCRPC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study page remains a 403 error, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:13:58.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The revision label in the site footer changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:26:00.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing detailed study content with a minimal error screen and a Home link. This indicates an access issue that prevents users from viewing the trial record as intended.
    Difference
    19%
    Check dated 2026-09-23T00:40:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0 in the Study Documents section, indicating an updated protocol/documentation. This change reflects a newer version of the study protocol and related documents linked on the page.
    Difference
    0.0%
    Check dated 2026-09-15T23:30:02.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, signaling a minor metadata/patch update to the page without changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-01T20:43:21.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    An NIH grant/contract identifier for 2018 was added to the study's list of identifiers, indicating NIH support for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T20:53:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in mCRPC Clinical Trial page.